LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.01
62.66 771.67 9357 8978 1.0422 1.0235
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
64.88 771.67 8094 9447 0.8568 0.9163
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
64.88 771.67 9737 9447 1.0307 1.0168
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
67.10 771.67 8402 9800 0.8573 0.9178
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
67.10 771.67 10120 9800 1.0326 1.0176
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
69.32 771.67 8498 10212 0.8322 0.9038
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
69.32 771.67 10613 10212 1.0393 1.0208
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
71.54 771.67 8758 10532 0.8315 0.9045
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
71.54 771.67 11024 10532 1.0466 1.0243
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
73.76 771.67 8921 10851 0.8221 0.8999
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
73.76 771.67 11418 10851 1.0522 1.0269
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
76.02 771.67 8937 11106 0.8047 0.8901
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
76.02 771.67 11771 11106 1.0598 1.0304
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
78.25 771.67 9092 11367 0.7998 0.8881
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
78.25 771.67 12218 11367 1.0748 1.0375
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
80.48 771.67 9118 11685 0.7803 0.8774
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
80.48 771.67 12467 11685 1.0669 1.0333
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
82.69 771.67 9129 11974 0.7624 0.8674
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
82.69 771.67 12851 11974 1.0732 1.0361
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
84.92 771.67 9075 12266 0.7398 0.8545
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
84.92 771.67 13282 12266 1.0828 1.0403
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
87.14 771.67 9037 12592 0.7177 0.8419
MN20160304_L01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
87.14 771.67 13658 12592 1.0846 1.0407
MN20160304_L01
F13
MCF 10A-H2B-mCherry Neratinib
0.018
2.49 771.67 883 867 1.0176 1.2168
MN20160304_L01
K03
MCF 10A-H2B-mCherry Neratinib
0.018
2.49 771.67 915 867 1.0545 1.7355
MN20160304_L01
N03